These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 6814451)

  • 1. Metabolic activation of ftorafur [R,S-1-(tetrahydro-2-furanyl)-5-fluorouracil]: the microsomal oxidative pathway.
    El Sayed YM; Sadée W
    Biochem Pharmacol; 1982 Sep; 31(18):3006-8. PubMed ID: 6814451
    [No Abstract]   [Full Text] [Related]  

  • 2. Metabolic activation of R,S-1-(tetrahydro-2-furanyl)-5-fluorouracil (ftorafur) to 5-fluorouracil by soluble enzymes.
    El Sayed YM; Sadée W
    Cancer Res; 1983 Sep; 43(9):4039-44. PubMed ID: 6409396
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytochrome P-450-dependent oxidative cleavage of 1-(tetrahydro-2-furanyl)-5-fluorouracil to 5-fluorouracil.
    Kawata S; Minami Y; Tarui S; Marunaka T; Okamoto M; Yamano T
    Jpn J Pharmacol; 1984 Sep; 36(1):43-9. PubMed ID: 6438379
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of Ftorafue [R,S-1-(tetrahydro-2-furanyl)-5-fluorouracil] to 5-fluorouracil and gamma-butyrolactone.
    Au JL; Sadée W
    Cancer Res; 1980 Aug; 40(8 Pt 1):2814-9. PubMed ID: 6771006
    [No Abstract]   [Full Text] [Related]  

  • 5. Stereoselective metabolism of ftorafur (R,S-1-(tetrahydro-2-furanyl)-5-fluorouracil).
    Au JL; Sadée W
    Cancer Chemother Pharmacol; 1981; 7(1):55-9. PubMed ID: 6804104
    [No Abstract]   [Full Text] [Related]  

  • 6. The pharmacology of ftorafur (R, S-1-(tetrahydro-2-furanyl)-5-fluorouracil.
    Au JL; Sadée W
    Recent Results Cancer Res; 1981; 76():100-14. PubMed ID: 6785848
    [No Abstract]   [Full Text] [Related]  

  • 7. Disposition and metabolism of 1-(tetrahydro-2-furanyl)-5-fluorouracil (ftorafur) in humans.
    Benvenuto JA; Lu K; Hall SW; Benjamin RS; Loo TL
    Cancer Res; 1978 Nov; 38(11 Pt 1):3867-70. PubMed ID: 359130
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of metabolites of 1-(tetrahydro-2-furanyl)-5-fluorouracil (FT-207) formed in vitro by rat liver microsomes.
    Marunaka T; Minami Y; Umeno Y; Yasuda A; Sato T; Fujii S
    Chem Pharm Bull (Tokyo); 1980 Jun; 28(6):1795-80. PubMed ID: 6773678
    [No Abstract]   [Full Text] [Related]  

  • 9. Enzymatic formation of 5-fluorouracil from 1-(tetrahydro-2-furanyl)- 5-fluorouracil (tegafur) in human tumor tissues.
    Kono A; Hara Y; Matsushima Y
    Chem Pharm Bull (Tokyo); 1981 May; 29(5):1486-8. PubMed ID: 6794918
    [No Abstract]   [Full Text] [Related]  

  • 10. Bioactivation of tegafur to 5-fluorouracil is catalyzed by cytochrome P-450 2A6 in human liver microsomes in vitro.
    Ikeda K; Yoshisue K; Matsushima E; Nagayama S; Kobayashi K; Tyson CA; Chiba K; Kawaguchi Y
    Clin Cancer Res; 2000 Nov; 6(11):4409-15. PubMed ID: 11106261
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Studies of antitumor agents. 1. Resolution of racemic 1-(tetrahydro-2-furanyl)-k-fluorouracil into the R and S isomers and examination of the biological activities of the isomers.
    Yasumoto M; Moriyama A; Unemi N; Hashimoto S; Suzue T
    J Med Chem; 1977 Dec; 20(12):1592-4. PubMed ID: 338900
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Roles of cytochromes P450 1A2, 2A6, and 2C8 in 5-fluorouracil formation from tegafur, an anticancer prodrug, in human liver microsomes.
    Komatsu T; Yamazaki H; Shimada N; Nakajima M; Yokoi T
    Drug Metab Dispos; 2000 Dec; 28(12):1457-63. PubMed ID: 11095583
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolism, antitumor activity, and acute toxicity of 5-fluoro-1,3-bis(tetrahydro-2-furanyl)-2,4-pyrimidinedione by oral administration to animals.
    Fujii S; Nakamura Y; Takeda S; Morita K; Sato T; Marunaka T; Kawaguchi Y; Unemi N
    Gan; 1980 Feb; 71(1):30-44. PubMed ID: 6769737
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hydroxylated metabolies of R,S-1-(tetrahydro-2-furanyl)-5-fluorouracil (Ftorafur) in rats and rabbits.
    Wu AT; Au JL; Sadée W
    Cancer Res; 1978 Jan; 38(1):210-4. PubMed ID: 338145
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics and metabolism of ftorafur in man.
    Au JL; Wu AT; Friedman MA; Sadée W
    Cancer Treat Rep; 1979 Mar; 63(3):343-50. PubMed ID: 371796
    [No Abstract]   [Full Text] [Related]  

  • 16. Studies to increase the antitumor activity of 1-(tetrahydro-2-furanyl)-5-fluorouracil and its metabolic aspects by combined administration with L-cysteine.
    Kawabata N; Sugiyama S; Kuwamura T; Satoh T; Kitagawa H
    Jpn J Pharmacol; 1983 Aug; 33(4):735-47. PubMed ID: 6415326
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatic conversion of 1-(tetrahydro-2-furanyl)-5-fluorouracil into 5-fluorouracil in patients with hepatocellular carcinoma.
    Kawata S; Noda S; Imai Y; Tamura S; Saitoh R; Miyoshi S; Minami Y; Tarui S
    Gastroenterol Jpn; 1987 Feb; 22(1):55-62. PubMed ID: 3032726
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Influence of immunopotentiators on the activation of 5-FU derivatives].
    Nakazato H; Kito T; Yasue M; Yamamura Y; Kobari T; Hirakawa T; Hatta M
    Gan To Kagaku Ryoho; 1985 Apr; 12(4):867-74. PubMed ID: 3920971
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Participation of non-specific rat liver microsome oxidases in destruction of Nl-furanidylpyrimidines].
    Meĭren DV; Urbanovich EL; Sniedze TN; Khagi KhB; Gilev AP
    Biull Eksp Biol Med; 1977 Feb; 83(2):162-4. PubMed ID: 15682
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytosolic and microsomal activation of doxifluridine and tegafur to produce 5-fluorouracil in human liver.
    Ozawa S; Hamada M; Murayama N; Nakajima Y; Kaniwa N; Matsumoto Y; Fukuoka M; Sawada J; Ohno Y
    Cancer Chemother Pharmacol; 2002 Dec; 50(6):454-8. PubMed ID: 12451471
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.